Registration - In-house Corporation

AbbVie Corporation / RAMI FAYED, Vice President and General Manager, Canada

Registration Information

In-house Corporation name: AbbVie Corporation
Previous in-house corporation names
Responsible Officer Name: RAMI FAYED, Vice President and General Manager, Canada
Responsible Officer Change History
Initial registration start date: 2007-04-25
Registration status: Active
Registration Number: 957373-15270

Associated Communications

Total Number of Communication Reports: 142

Monthly communication reports in the last 6 months: 8

Version 13 of 40 (2014-09-15 to 2015-01-05)

Registration versions:

Version 13 of 40 (2014-09-15 to 2015-01-05)

Lobbying Information

Subject Matters

Aboriginal Affairs
Health
Industry
Intellectual Property
International Trade
Science and Technology
Taxation and Finance

Subject Matter Details

Legislative Proposal, Bill or Resolution, Policies or Program

Pharmaceutical intellectual property proposals that are part of the Comprehensive Economic and Trade Agreement with the European Union.

Legislative Proposal, Bill or Resolution, Policies or Program, Regulation

Acts that propose to amend the Food and Drug Act and amendments to the Food and Drug Regulations related to the regulation of pharmaceuticals, biologic therapies, medical devices and foods.

Legislative Proposal, Bill or Resolution, Regulation

Similar Entry Biologics (SEBs): requiring a Health Canada regulatory framework that support the approval of SEBs

Policies or Program

Common Drug Review (CDR), with respect to health economics assessment and recommendations made on new medicines.
Federal Government Non Insured Health Benefits program with respect to reimbursement of a prescription medicine and changes in type of reimbursement

Regulation

Industry Canada Patented Medicines Notice of Compliance (PMNOC) Regulations, as this relates to regulating intellectual property of prescription drugs
Patented Medicine Prices Review Board (PMPRB) Regulations. with regard to prices charged by patentees for patented medicines sold in Canada.

Communication Techniques

Written communication
Oral communication

Government Institutions

Aboriginal Affairs and Northern Development Canada
Canadian Institutes of Health Research (CIHR)
Correctional Service of Canada (CSC)
Finance Canada (FIN)
Foreign Affairs and International Trade Canada (DFAITC)
Health Canada (HC)
House of Commons
Immigration and Refugee Board (IRB)
Industry Canada
National Defence (DND)
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Public Health Agency of Canada (PHAC)
Public Works and Government Services Canada
Royal Canadian Mounted Police (RCMP)
Veterans Affairs Canada (VAC)

Government institutions added through a monthly communication report

Senate of Canada

In-house Corporation Details

Description of activities

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott. With its 125-year history, the company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases.

Responsible officer name and position during the period of this registration

Felipe Pastrana, General Manager

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
8401 Transcanada Highway
St-Laurent, QC H4S 1Z1
Canada

Telephone number: 514-832-7126
Fax number: 514-832-7858

Parent Company Information

AbbVie
- 100 Abbott Park Rd
  Abbott Park, IL 60064-3500
  United States of America

Subsidiary Beneficiary Information

AbbVie Corporation does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Linda Assouline, Medical Director | No public offices held
Loretta Del Bosco, Director, Regulatory Affairs & Quality Assurance | No public offices held
Laurie Dotto, Director Government & External Affairs | No public offices held
Caroline Jacques, Senior Counsel, Latin America, Canada | No public offices held
David Link, National Manager Market Access & Governmental Affairs | No public offices held
Judith Mergl, Senior Manager Regulatory Affairs | No public offices held
Diana Parison, Senior Manager Market Access Planning & HE | No public offices held
Felipe Pastrana, General Manager | No public offices held
Andrew Wynn, Provincial Affairs Manager | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Philip Schwab, Senior Manager, Federal Government Affairs | No public offices held

AbbVie Corporation

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
AbbVie Corporation	2024-05-28	current
AbbVie Corporation	2013-04-25	2024-05-28
Abbott Laboratories	2008-07-02	2013-04-25

The following names have been used before July 2, 2008

Abbott Laboratories
Abbott Laboratories, Limited

AbbVie Corporation

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
RAMI FAYED	2024-02-01	Current
Tracey Ramsay	2021-02-01	2024-02-01
Denis Hello	2020-03-01	2021-02-01
Stéphane Lassignardie	2015-01-05	2020-03-01
Felipe Pastrana	2011-04-01	2015-01-05
Jeffrey Devlin	2007-04-25	2011-04-01

RAMI FAYED, Vice President and General Manager, Canada (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-142 of 142

AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Madeleine Fequiere, Consul General of Canada in Chicago | Global Affairs Canada (GAC)
Subject Matter of the communication: Health, Industry
Communication date: 2024-06-13
Posted date: 2024-07-15
Communication number: 15270-609737 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Scott Doidge, Director General | Non-Insured Health Benefits Directorate | Indigenous Services Canada (ISC)
Subject Matter of the communication: Health
Communication date: 2024-06-11
Posted date: 2024-07-15
Communication number: 15270-608374 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Harold Dremin, Chief of Investor Services | Invest in Canada Hub
Subject Matter of the communication: Economic Development, Research and Development
Communication date: 2024-06-04
Posted date: 2024-07-15
Communication number: 15270-606247 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Research and Development
Communication date: 2024-06-03
Posted date: 2024-07-15
Communication number: 15270-606246 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- James Van Raalte, Executive Director RPCD | Treasury Board Of Canada Secretariat (TBS)
Subject Matter of the communication: Intellectual Property
Communication date: 2024-05-09
Posted date: 2024-06-15
Communication number: 15270-605658 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Francis Bilodeau, Associate Deputy Minister | Office of the Associate Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Andrea Johnston, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Etienne-Rene Massie, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2024-04-15
Posted date: 2024-05-15
Communication number: 15270-601161 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mark Schaan, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry
Communication date: 2024-04-15
Posted date: 2024-05-15
Communication number: 15270-601160 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Christopher Johnstone, Assistant Deputy Minister | Health Canada (HC)
- Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry, Research and Development
Communication date: 2024-04-03
Posted date: 2024-05-15
Communication number: 15270-601209 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- William Messier, Quebec Advisor to the Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2024-02-12
Posted date: 2024-03-15
Communication number: 15270-592450 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Helena Jaczek, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2023-12-19
Posted date: 2024-01-15
Communication number: 15270-589347 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
- Laurel Broten, Chief Executive Officer | Invest in Canada Hub
- Bobby Kelly, Chief of Staff | Invest in Canada Hub
- Kelley Parato, Director | Human Health Therapeutics Research Centre | National Research Council (NRC)
Subject Matter of the communication: Health, Industry, Science and Technology
Communication date: 2023-11-09
Posted date: 2023-12-15
Communication number: 15270-585719 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Chiang, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2023-10-26
Posted date: 2023-11-15
Communication number: 15270-580505 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Eshan Naik, Director of Policy | Office of the Minister of Health | House of Commons
Subject Matter of the communication: Health
Communication date: 2023-10-20
Posted date: 2023-11-15
Communication number: 15270-580181 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stan Kutcher, Senator | Senate of Canada
Subject Matter of the communication: Health
Communication date: 2023-08-31
Posted date: 2023-09-15
Communication number: 15270-575644 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Yash Nanda, Policy Advisor | Finance Canada (FIN)
Subject Matter of the communication: Health, Industry
Communication date: 2023-07-27
Posted date: 2023-08-18
Communication number: 15270-575175 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Husain Aboghodieh, Policy Advisor | Global Affairs Canada (GAC)
Subject Matter of the communication: Industry
Communication date: 2023-05-17
Posted date: 2023-06-15
Communication number: 15270-566531 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mohamed-Iqbal Ravalia, Senator | Senate of Canada
Subject Matter of the communication: Health
Communication date: 2023-05-17
Posted date: 2023-06-15
Communication number: 15270-566530 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2023-04-25
Posted date: 2023-05-15
Communication number: 15270-563714 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ed Morgan, Director General, Policy, Planning and International Affairs | Health Products and Food Branch | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2023-04-25
Posted date: 2023-05-15
Communication number: 15270-563713 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jocelyne Voisin, ADM | Strategic Policy Branch | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2023-04-25
Posted date: 2023-05-15
Communication number: 15270-563712 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Suki Wong, Director General, Mental Health Directorate | Strategic Policy Branch | Health Canada (HC)
- Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
- Eric Belair, Associate Assistant Deputy Minister | Strategic Policy Branch | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2023-04-24
Posted date: 2023-05-15
Communication number: 15270-563711 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Majid Jowhari, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2023-04-20
Posted date: 2023-05-15
Communication number: 15270-563391 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Robert Kitchen, Member of Parlilament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2023-03-30
Posted date: 2023-04-15
Communication number: 15270-560863 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Susan Fitzpatrick, Head, Canada Drug Agency Transition Office | Office of Pharmaceuticals Management Strategies | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2023-03-21
Posted date: 2023-04-15
Communication number: 15270-560437 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jordan Ames-Sinclair, Special Assistant, Policy | Minister's Office | Health Canada (HC)
- Emelyana Titarenko, Communications and Issues Manager | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2023-03-21
Posted date: 2023-04-15
Communication number: 15270-560435 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jamie Innes, Chief of Staff to the Minister | Intergovernmental Affairs Secretariat (IGA)
Subject Matter of the communication: Health, Industry
Communication date: 2022-12-14
Posted date: 2023-01-16
Communication number: 15270-552709 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jeff Waring, Director of Operations, Social Development Policy | Privy Council Office (PCO)
Subject Matter of the communication: Health, Industry
Communication date: 2022-12-14
Posted date: 2023-01-16
Communication number: 15270-552270 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Helen Gao, A/Chief of Staff | Indigenous Services Canada (ISC)
Subject Matter of the communication: Health, Aboriginal Affairs
Communication date: 2022-12-13
Posted date: 2023-01-16
Communication number: 15270-551201 (amended from 15270-551195) View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Steven MacKinnon, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2022-12-06
Posted date: 2023-01-16
Communication number: 15270-551200 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Robert Morrissey, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2022-12-06
Posted date: 2023-01-16
Communication number: 15270-551199 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Heath MacDonald, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2022-12-06
Posted date: 2023-01-16
Communication number: 15270-551198 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sameer Ahmed, Acting Consul General | Consulate General of Canada, Chicago | Global Affairs Canada (GAC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-12-05
Posted date: 2023-01-16
Communication number: 15270-551194 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Eric Belair, Associate Assistant Deputy Minister | Strategic Policy Branch | Health Canada (HC)
- Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-11-30
Posted date: 2022-12-15
Communication number: 15270-548735 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Yash Nanda, Senior Policy Advisor | Finance Canada (FIN)
Subject Matter of the communication: Health, Industry
Communication date: 2022-11-11
Posted date: 2022-12-15
Communication number: 15270-546187 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Shaili Patel, Director of Policy | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2022-11-10
Posted date: 2022-11-11
Communication number: 15270-546186 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
- Michelle Mujoomdar, Director, Specialty Pharmaceuticals | Health Canada (HC)
- Samir Khan, Director, Policy Division | Health Canada (HC)
- Daniel MacDonald, Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-11-07
Posted date: 2022-12-15
Communication number: 15270-546188 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2022-10-27
Posted date: 2022-11-03
Communication number: 15270-545249 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-10-26
Posted date: 2022-11-03
Communication number: 15270-545248 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dr. Stephen Ellis, Member of Parliament | House of Commons
- Allison Haley, Director, Parliamentary Affairs | Office, Dr. Stephen Ellis | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2022-10-25
Posted date: 2022-11-03
Communication number: 15270-545247 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jordan Ames-Sinclair, Special Assistant, Policy | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2022-09-06
Posted date: 2022-09-06
Communication number: 15270-540821 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bianca Hossain, Sr Special Assistant (Policy and Operations) | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2022-08-23
Posted date: 2022-08-23
Communication number: 15270-540434 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Yash Nanda, Senior Policy Advisor | Finance Canada (FIN)
Subject Matter of the communication: Health, Industry
Communication date: 2022-08-10
Posted date: 2022-08-10
Communication number: 15270-539492 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
- Samir Khan, Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-06-24
Posted date: 2022-06-24
Communication number: 15270-536285 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)
- Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-06-21
Posted date: 2022-06-24
Communication number: 15270-536284 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Darryl Patterson, Director General | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2022-06-13
Posted date: 2022-06-19
Communication number: 15270-536040 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Hilary Peirce, Senior Policy Advisor | Office of the President of the Treasury Board | Treasury Board Of Canada Secretariat (TBS)
Subject Matter of the communication: Health, Industry
Communication date: 2022-06-01
Posted date: 2022-06-03
Communication number: 15270-533273 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jean-Sebastien Bock, Director of Policy | Office of the Minister of Health | Health Canada (HC)
- Jamie Kippen, Chief of Staff | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-05-31
Posted date: 2022-06-03
Communication number: 15270-533272 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Adam Van Koeverden, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2022-05-31
Posted date: 2022-06-03
Communication number: 15270-533271 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ed Morgan, Director General | Policy, Planning and International Affairs Directorate | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2022-05-31
Posted date: 2022-06-03
Communication number: 15270-533270 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dr. Stephen Ellis, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2022-05-31
Posted date: 2022-06-03
Communication number: 15270-533269 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Boudreau, Executive Director | Office of Pharmaceutical Management Strategies | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-05-30
Posted date: 2022-06-03
Communication number: 15270-533268 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-05-17
Posted date: 2022-05-19
Communication number: 15270-532600 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Industry
Communication date: 2022-04-14
Posted date: 2022-04-29
Communication number: 15270-530329 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Darryl Patterson, Director General | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2022-04-12
Posted date: 2022-04-29
Communication number: 15270-530327 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-03-17
Posted date: 2022-03-21
Communication number: 15270-526870 (amended from 15270-526869) View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sandenga Yeba, Senior Policy Advisor - Quebec Desk | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-02-03
Posted date: 2022-02-07
Communication number: 15270-521145 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tyler Norman, Regional Advisor | Minister's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2022-02-01
Posted date: 2022-02-07
Communication number: 15270-521144 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dylan Marando, Senior Policy Advisor | Minister's Office | Prime Minister's Office (PMO)
Subject Matter of the communication: Health
Communication date: 2021-11-25
Posted date: 2021-12-15
Communication number: 15270-516377 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Wayne Robson, Acting Consul General of Canada in Chicago | Global Affairs Canada (GAC)
- Molly Banuelos, Trade Commissioner/Life Sciences at Consulate General of Canada in Chicago | Global Affairs Canada (GAC)
Subject Matter of the communication: Health, Industry
Communication date: 2021-06-22
Posted date: 2021-07-15
Communication number: 15270-509471 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bob Saroya, Member of Parliament | House of Commons
- Ryan Ouderkirk, Parliamentary Assistant | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2021-06-18
Posted date: 2021-07-15
Communication number: 15270-509226 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Justin Riemer, Assistant Deputy Minister, Alberta | Western Economic Diversification Canada | Western Economic Diversification Canada (WD)
Subject Matter of the communication: Health, Industry
Communication date: 2021-06-07
Posted date: 2021-07-15
Communication number: 15270-506891 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Francis Scarpaleggia, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2021-05-11
Posted date: 2021-06-15
Communication number: 15270-506002 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bob Saroya, Member of Parliament | House of Commons
- Christopher Poulos, Constituency Assistant | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2021-05-07
Posted date: 2021-06-15
Communication number: 15270-503795 (amended from 15270-503788) View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Holly Duggan, Stakeholder Relations Advisor | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2021-05-05
Posted date: 2021-05-07
Communication number: 15270-503794 (amended from 15270-503687) View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tom Kmiec, Member of Parliament | House of Commons
- Alyssa Doig, Member's Assistant | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2021-04-20
Posted date: 2021-05-15
Communication number: 15270-503792 (amended from 15270-503075) View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Earl Dreeshen, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2021-04-15
Posted date: 2021-05-15
Communication number: 15270-503791 (amended from 15270-502621) View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Frank Baylis, Member of Parliament | House of Commons | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2019-01-30
Posted date: 2019-02-04
Communication number: 15270-444401 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Richard Botham, Assistant Deputy Minister | Finance Canada (FIN)
Subject Matter of the communication: Health, Industry, Taxation and Finance
Communication date: 2018-03-29
Posted date: 2018-03-29
Communication number: 15270-422901 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Frank Baylis, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2017-12-07
Posted date: 2017-12-08
Communication number: 15270-414874 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Deputy Minister | Health Canada (HC)
- Abby Hoffman, Assistant Deputy Minister | Health Canada (HC)
- Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)
- Kendall Webber, Associate Assistant Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2017-11-14
Posted date: 2017-11-24
Communication number: 15270-414194 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kyle Peterson, House of Commons | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2017-11-09
Posted date: 2017-11-24
Communication number: 15270-414193 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rob Oliphant, House of Commons | House of Commons
Subject Matter of the communication: Health
Communication date: 2017-11-08
Posted date: 2017-11-24
Communication number: 15270-414190 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Don Davies, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2017-11-08
Posted date: 2017-11-24
Communication number: 15270-414188 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rob Oliphant, Member of Parliament | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2017-10-31
Posted date: 2017-11-24
Communication number: 15270-414187 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Parvidner Sachdeva, Policy Advisor | Minister of Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2017-08-30
Posted date: 2017-08-30
Communication number: 15270-407186 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Emmanuella Lambropoulos, Member of Parliament | St-Laurent | House of Commons
Subject Matter of the communication: Health, Industry, Science and Technology
Communication date: 2017-08-29
Posted date: 2017-08-30
Communication number: 15270-407185 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Frank Baylis, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2017-01-19
Posted date: 2017-02-07
Communication number: 15270-393324 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Francis Scarpaleggia, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2017-01-19
Posted date: 2017-02-07
Communication number: 15270-393323 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Siddika Mithani, President | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2017-01-04
Posted date: 2017-01-11
Communication number: 15270-392304 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Halucha, Assistant Deputy Minister | Life Sciences and Manufacturing Branch | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Intellectual Property
Communication date: 2016-11-01
Posted date: 2016-11-04
Communication number: 15270-386667 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2016-11-01
Posted date: 2016-11-04
Communication number: 15270-386663 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ashleigh White, Special Assistant | Minister of Health's Office | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2016-09-20
Posted date: 2016-11-04
Communication number: 15270-386661 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kyle Peterson, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology, International Trade
Communication date: 2016-06-16
Posted date: 2016-06-23
Communication number: 15270-380295 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Don Davies, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
Communication date: 2016-06-01
Posted date: 2016-06-23
Communication number: 15270-380294 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rob Oliphant, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2016-05-12
Posted date: 2016-05-13
Communication number: 15270-376874 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rachael Harder, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2016-05-11
Posted date: 2016-05-13
Communication number: 15270-376870 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kelvin K. Ogilvie, Honourable Senator | Senate of Canada
Subject Matter of the communication: Health, Industry, Science and Technology
Communication date: 2016-04-13
Posted date: 2016-04-14
Communication number: 15270-374511 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Nancy Greene Raine, Honourable Senator | Senate of Canada
Subject Matter of the communication: Health, Industry, Science and Technology
Communication date: 2016-04-12
Posted date: 2016-04-14
Communication number: 15270-374510 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- David Clements, Director of Communications | Office of the Minister of Health | Health Canada (HC)
- Jesse Kancir, Policy Advisor | Office of the Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2016-04-11
Posted date: 2016-04-14
Communication number: 15270-374512 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Robert Oliphant, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2016-04-11
Posted date: 2016-04-14
Communication number: 15270-374508 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Carol Hughes, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Aboriginal Affairs
Communication date: 2016-03-09
Posted date: 2016-03-14
Communication number: 15270-371779 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Knubley, Deputy Minister | Industry Canada
- Paul Halucha, Associate Assistant Deputy Minister | Strategic Policy Sector | Industry Canada
Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology, International Trade
Communication date: 2015-04-15
Posted date: 2015-05-06
Communication number: 15270-352962 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Carol Hughes, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2015-01-28
Posted date: 2015-02-16
Communication number: 15270-347353 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Carolyn Bennett, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2015-01-27
Posted date: 2015-02-16
Communication number: 15270-347351 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ralph Goodalde, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Aboriginal Affairs
Communication date: 2014-12-16
Posted date: 2015-01-15
Communication number: 15270-342997 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Libby Davies, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2014-10-21
Posted date: 2014-11-15
Communication number: 15270-338850 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kelvin Ogilvie, Senator | Senate of Canada
Subject Matter of the communication: Health
Communication date: 2014-10-20
Posted date: 2014-11-15
Communication number: 15270-338851 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Irene Mathyssen, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2014-10-20
Posted date: 2014-11-15
Communication number: 15270-338849 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Megan Leslie, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2014-09-25
Posted date: 2014-11-15
Communication number: 15270-338852 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Carolyn Bennett, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2014-09-04
Posted date: 2014-09-15
Communication number: 15270-333534 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Lois Brown, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2014-08-28
Posted date: 2014-09-15
Communication number: 15270-333533 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rainer Englehardt, Chief Science Officer | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2014-05-28
Posted date: 2014-06-15
Communication number: 15270-327994 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stephane Dion, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2014-05-28
Posted date: 2014-06-15
Communication number: 15270-327992 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Joe Daniel, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2014-05-27
Posted date: 2014-06-15
Communication number: 15270-327991 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rod Bruinooge, Member of Parliament, Winnipeg South | House of Commons
Subject Matter of the communication: Health, Aboriginal Affairs
Communication date: 2013-04-30
Posted date: 2013-05-15
Communication number: 15270-271751 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ted Laking, Policy Advisor | Health Canada (HC)
Subject Matter of the communication: Health, Aboriginal Affairs
Communication date: 2013-04-30
Posted date: 2013-05-15
Communication number: 15270-271750 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rob Clarke, Member of Parliament, Desnethe-Missinippi-Churchill | House of Commons
Subject Matter of the communication: Health, Aboriginal Affairs
Communication date: 2013-04-30
Posted date: 2013-05-15
Communication number: 15270-271749 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Andrew Rankin, Policy Advisor | Finance Canada (FIN)
- Samuel VanderVeer, Policy Advisor | Finance Canada (FIN)
Subject Matter of the communication: Health, Aboriginal Affairs
Communication date: 2012-10-31
Posted date: 2012-11-15
Communication number: 15270-245569 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Phil Harwood, Policy Advisor | Prime Minister's Office (PMO)
- Drew Campbell, Manager, Stakeholder Relations | Prime Minister's Office (PMO)
Subject Matter of the communication: Health, Science and Technology
Communication date: 2012-09-18
Posted date: 2012-10-15
Communication number: 15270-238810 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Colin Carrie, MP - Oshawa | House of Commons
Subject Matter of the communication: Health
Communication date: 2012-09-18
Posted date: 2012-10-15
Communication number: 15270-238809 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Lisa Raitt, Minister of Labour | House of Commons
- Michael Beaton, Director of Policy | House of Commons
- Jana Regimbal, Special Assistant | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2012-08-07
Posted date: 2012-09-15
Communication number: 15270-235089 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Philip Jennings, Associate Assisstant Deputy Minister | Industry Canada
Subject Matter of the communication: Health, Intellectual Property, Science and Technology
Communication date: 2012-05-23
Posted date: 2012-06-15
Communication number: 15270-224988 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kellie Leitch, MP Simcoe-Grey | House of Commons
Subject Matter of the communication: Health
Communication date: 2012-05-10
Posted date: 2012-06-01
Communication number: 15270-224987 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Phil Harwood, Policy Advisor | Prime Minister's Office (PMO)
- Julie Gaudreau, Senior Advisor | Prime Minister's Office (PMO)
Subject Matter of the communication: Health
Communication date: 2012-03-05
Posted date: 2012-04-16
Communication number: 15270-218307 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Leona Aglukkaq, Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2012-03-01
Posted date: 2012-04-16
Communication number: 15270-218308 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Andre Bellavance, MP - Richmond-Arthabaska | House of Commons
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2012-03-01
Posted date: 2012-04-16
Communication number: 15270-211352 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Carol Hughes, MP - Algoma--Manitoulin--Kapuskasing | House of Commons
Subject Matter of the communication: Health
Communication date: 2012-03-01
Posted date: 2012-04-16
Communication number: 15270-211351 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stephane Dion, MP- Ville-St-Laurent-Cartierville | House of Commons
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2012-03-01
Posted date: 2012-04-16
Communication number: 15270-211350 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Andrew Rankin, Policy Advisor | Finance Canada (FIN)
Subject Matter of the communication: Health
Communication date: 2012-02-15
Posted date: 2012-03-16
Communication number: 15270-211349 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rob Clark, MP - Desnethé—Missinippi—Churchill River | House of Commons
Subject Matter of the communication: Health
Communication date: 2012-02-02
Posted date: 2012-03-16
Communication number: 15270-211348 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dean Del Mastro, MP - Peterborough | House of Commons
Subject Matter of the communication: Health
Communication date: 2012-02-02
Posted date: 2012-03-16
Communication number: 15270-211347 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dany Morin, MP - Chicoutimi--Le Fjord | House of Commons
Subject Matter of the communication: Health
Communication date: 2011-11-17
Posted date: 2011-12-16
Communication number: 15270-200108 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rob Clarke, MP - Desnethé--Missinippi--Churchill River, | House of Commons
- Shelly Glover, MP - Saint-Boniface | House of Commons
- Peter Penashue, MP - Labrador | House of Commons
Subject Matter of the communication: Health
Communication date: 2011-11-03
Posted date: 2011-12-16
Communication number: 15270-192471 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Andrew Rankin, Policy Advisor | Finance Canada (FIN)
Subject Matter of the communication: Health
Communication date: 2011-11-03
Posted date: 2011-12-16
Communication number: 15270-192469 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kellie Leitch, MP Simcoe-Grey | House of Commons
- Colin Carrie, MP Oshawa | House of Commons
Subject Matter of the communication: Health
Communication date: 2011-11-01
Posted date: 2011-12-16
Communication number: 15270-191604 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kirsty Duncan, MP Etobicoke North | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2011-10-31
Posted date: 2011-11-16
Communication number: 15270-191603 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John McCallum, MP Markham-Unionville | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2011-10-24
Posted date: 2011-11-16
Communication number: 15270-191599 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Brad Butt, MP Mississauga-Streetsville | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2011-10-19
Posted date: 2011-11-16
Communication number: 15270-191597 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gord Brown, MP Leeds-Grenville | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2011-10-18
Posted date: 2011-11-16
Communication number: 15270-191593 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Andrea McGuigan, Policy Advisor | Prime Minister's Office (PMO)
- Sean Speer, Director, Stakeholder Relations | Prime Minister's Office (PMO)
- Gary Goodyear, Minister of State for Science and Technology | Industry Canada
- Ève Peclet, Member of Parliament | La Point-de-l'ile | House of Commons
- Kellie Leitch, Member of Parliament | Simcoe-Grey | House of Commons
- Glenn Thibault, Member of Parliament | Sudbury | House of Commons
Subject Matter of the communication: Health, Intellectual Property, Taxation and Finance
Communication date: 2011-09-20
Posted date: 2011-10-16
Communication number: 15270-188028 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Raymond Coté, Member of Parliament | Beauport Limoilou | House of Commons
Subject Matter of the communication: Health
Communication date: 2011-09-20
Posted date: 2011-10-16
Communication number: 15270-188027 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ed Fast, Minister of International Trade and for the Asia-Pacific Gateway | Foreign Affairs and International Trade Canada (DFAITC)
- Michelle Boudreau, Executive Director, Patented Medicine Prices Review Board | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2011-09-13
Posted date: 2011-10-16
Communication number: 15270-188448 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rob Clarke, Member of Parliament | Desnethé–Missinippi–Churchill River | House of Commons
Subject Matter of the communication: Health, Aboriginal Affairs
Communication date: 2011-09-08
Posted date: 2011-10-16
Communication number: 15270-188045 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Lois Brown, Member of Parliament Newmarket | House of Commons
Subject Matter of the communication: Health
Communication date: 2011-06-01
Posted date: 2011-07-16
Communication number: 15270-174284 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Francis Scarpalegia, MP: Lac-Saint-Louis | House of Commons
- Stephane Dion, MP: Saint Laurent-Cartierville | House of Commons
- John McCallum, MP: Markham-Unionville | House of Commons
Subject Matter of the communication: Intellectual Property
Communication date: 2011-03-03
Posted date: 2011-04-16
Communication number: 15270-169186 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Luc Malo, MP: Vercheres/Les Patriots | House of Commons
- Andre Bellavance, MP - Richmond-Arthabaska | House of Commons
Subject Matter of the communication: Intellectual Property
Communication date: 2011-03-02
Posted date: 2011-04-16
Communication number: 15270-169185 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gord Brown, MP - Leeds-Grenville | House of Commons
Subject Matter of the communication: Industry, Intellectual Property
Communication date: 2010-10-18
Posted date: 2010-11-01
Communication number: 15270-158172 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rob Clarke, Member of Parliament | Desnethé–Missinippi–Churchill River | House of Commons
- Rob Clarke, Member of Parliament | Houe of Commons | House of Commons
Subject Matter of the communication: Health care policy
Communication date: 2010-09-08
Posted date: 2011-10-03
Communication number: 15270-188024 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Leah Canning, Director of Policy | Health Canada | Health Canada (HC)
Subject Matter of the communication: Health care policy
Communication date: 2010-06-25
Posted date: 2010-07-19
Communication number: 15270-152497 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Laurie Throness, Minister's Chief of Staff | Minister's Office INAC | Aboriginal Affairs and Northern Development Canada
Subject Matter of the communication: Health, Aboriginal Affairs
Communication date: 2010-05-06
Posted date: 2010-05-17
Communication number: 15270-148376 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Leah Canning, Senior Policy Advisor | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health care policy, Aboriginal Affairs
Communication date: 2010-04-12
Posted date: 2010-05-17
Communication number: 15270-148373 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dave Forestell, Policy Advisor | Prime Minister's Office | Prime Minister's Office (PMO)
Subject Matter of the communication: Health
Communication date: 2010-03-31
Posted date: 2010-04-15
Communication number: 15270-146114 View associated registration

RAMI FAYED, Vice President and General Manager, Canada (Corporation)

Learn more...

Results below are sorted by posted date, beginning with the most recent.

Results 1-142 of 142

AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Madeleine Fequiere, Consul General of Canada in Chicago | Global Affairs Canada (GAC)
Subject Matter of the communication: Health, Industry
Communication date: 2024-06-13
Posted date: 2024-07-15
Communication number: 15270-609737 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Scott Doidge, Director General | Non-Insured Health Benefits Directorate | Indigenous Services Canada (ISC)
Subject Matter of the communication: Health
Communication date: 2024-06-11
Posted date: 2024-07-15
Communication number: 15270-608374 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Harold Dremin, Chief of Investor Services | Invest in Canada Hub
Subject Matter of the communication: Economic Development, Research and Development
Communication date: 2024-06-04
Posted date: 2024-07-15
Communication number: 15270-606247 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Research and Development
Communication date: 2024-06-03
Posted date: 2024-07-15
Communication number: 15270-606246 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- James Van Raalte, Executive Director RPCD | Treasury Board Of Canada Secretariat (TBS)
Subject Matter of the communication: Intellectual Property
Communication date: 2024-05-09
Posted date: 2024-06-15
Communication number: 15270-605658 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Francis Bilodeau, Associate Deputy Minister | Office of the Associate Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Andrea Johnston, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Etienne-Rene Massie, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2024-04-15
Posted date: 2024-05-15
Communication number: 15270-601161 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mark Schaan, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry
Communication date: 2024-04-15
Posted date: 2024-05-15
Communication number: 15270-601160 View associated registration
AbbVie Corporation
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Christopher Johnstone, Assistant Deputy Minister | Health Canada (HC)
- Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry, Research and Development
Communication date: 2024-04-03
Posted date: 2024-05-15
Communication number: 15270-601209 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

AbbVie Corporation / RAMI FAYED, Vice President and General Manager, Canada

Registration Information

Associated Communications

Version 13 of 40 (2014-09-15 to 2015-01-05)

Version 13 of 40 (2014-09-15 to 2015-01-05)

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution, Policies or Program

Legislative Proposal, Bill or Resolution, Policies or Program, Regulation

Legislative Proposal, Bill or Resolution, Regulation

Policies or Program

Regulation

Communication Techniques

Government Institutions

Government institutions added through a monthly communication report

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties